Alerts will be sent to your verified email
Verify Email
ACCPL
|
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
72.47 % | 9.28 % | 15.94 % |
|
5yr Avg Net Profit Margin
|
11.51 % | 10.38 % | 14.61 % |
|
Price to Book
|
0.0 | 2.59 | 1.62 |
|
P/E
|
9.86 | 37.43 | 12.58 |
|
5yr Avg Cash Conversion Cycle
|
108.78 Days | -14.29 Days | 24.49 Days |
|
5yr Average Interest Coverage Ratio
|
5.99 | 5.43 | 58.2 |
|
5yr Avg ROCE
|
55.84 % | 10.08 % | 20.48 % |
|
5yr Avg Operating Profit Margin
|
22.25 % | 24.06 % | 18.48 % |
|
5 yr average Debt to Equity
|
2.52 | 0.47 | 0.0 |
|
5yr CAGR Net Profit
|
117.34 % | 3.94 % | 12.65 % |
|
5yr Average Return on Assets
|
14.33 % | 5.37 % | 12.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 52.86 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.68 % | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|---|